Product Code: ETC6426378 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bhutan Plasma Protease C1-Inhibitor Market Overview |
3.1 Bhutan Country Macro Economic Indicators |
3.2 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume, 2021 & 2031F |
3.3 Bhutan Plasma Protease C1-Inhibitor Market - Industry Life Cycle |
3.4 Bhutan Plasma Protease C1-Inhibitor Market - Porter's Five Forces |
3.5 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume Share, By End-user, 2021 & 2031F |
3.6 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Bhutan Plasma Protease C1-Inhibitor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hereditary angioedema (HAE) in Bhutan |
4.2.2 Growing awareness and diagnosis of HAE and related conditions |
4.2.3 Advancements in plasma protease C1-inhibitor therapies |
4.3 Market Restraints |
4.3.1 High cost associated with plasma protease C1-inhibitor treatment |
4.3.2 Limited access to specialized healthcare facilities in Bhutan |
4.3.3 Regulatory hurdles in approving and distributing plasma protease C1-inhibitor products |
5 Bhutan Plasma Protease C1-Inhibitor Market Trends |
6 Bhutan Plasma Protease C1-Inhibitor Market, By Types |
6.1 Bhutan Plasma Protease C1-Inhibitor Market, By End-user |
6.1.1 Overview and Analysis |
6.1.2 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume, By End-user, 2021- 2031F |
6.1.3 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume, By Hospital pharmacy, 2021- 2031F |
6.1.4 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume, By Retail pharmacy, 2021- 2031F |
6.1.5 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume, By Online pharmacy, 2021- 2031F |
6.2 Bhutan Plasma Protease C1-Inhibitor Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume, By Lyophilized, 2021- 2031F |
6.2.3 Bhutan Plasma Protease C1-Inhibitor Market Revenues & Volume, By Injectable, 2021- 2031F |
7 Bhutan Plasma Protease C1-Inhibitor Market Import-Export Trade Statistics |
7.1 Bhutan Plasma Protease C1-Inhibitor Market Export to Major Countries |
7.2 Bhutan Plasma Protease C1-Inhibitor Market Imports from Major Countries |
8 Bhutan Plasma Protease C1-Inhibitor Market Key Performance Indicators |
8.1 Patient adherence rate to plasma protease C1-inhibitor treatment |
8.2 Number of healthcare professionals trained in diagnosing and treating HAE |
8.3 Frequency of HAE awareness campaigns in Bhutan |
9 Bhutan Plasma Protease C1-Inhibitor Market - Opportunity Assessment |
9.1 Bhutan Plasma Protease C1-Inhibitor Market Opportunity Assessment, By End-user, 2021 & 2031F |
9.2 Bhutan Plasma Protease C1-Inhibitor Market Opportunity Assessment, By Product, 2021 & 2031F |
10 Bhutan Plasma Protease C1-Inhibitor Market - Competitive Landscape |
10.1 Bhutan Plasma Protease C1-Inhibitor Market Revenue Share, By Companies, 2024 |
10.2 Bhutan Plasma Protease C1-Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |